Evidence Library

Showing 2 of 2 results.
Sarah B. Klieger, MPH •
Center for Public Health Law Research
Abraham Gutman, MA •
Center for Public Health Law Research
Leslie Allen, JD •
Women Against Abuse, Inc.
Rosalie Pacula, PhD •
Jennifer Ibrahim, PhD, MPH, MA •
Temple University
Scott Burris, JD •
Center for Public Health Law Research

As of February 1, 2017 state laws disparately regulate patient registration and civil rights, product safety labeling and packaging, and dispensaries, creating a patchwork of regulatory strategies whose effectiveness remains unknown.

Aaron Kesselheim, MD, JD, MPH •
Brigham & Women’s Hospital

Aaron Kesselheim, MD, JD, MPH, of the Division of Pharmacoepidemiology & Pharmacoeconomics at Brigham and Women’s Hospital discusses the effects on medical innovation of statutes that provide additional intellectual property rights or related incentives to pharmaceutical, medical device, and biotechnology developers in the U.S.